Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus Disease

NCT05597735 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT05597735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus Disease
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 3, 2023
Completion date
September 30, 2026
Enrollment
480 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

monkeypox, mpox